Results 201 to 210 of about 619,448 (301)

Assessment of and Response to Data Needs of Clinical and Translational Science Researchers and Beyond

, 2016
Hannah Norton, Michele R. Tennant, Cecilia Botero, Rolando García-Milian   +3 more
openalex   +2 more sources

Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To project ALS prevalence across multiple countries through 2040, accounting for both population aging and increased survival. Methods Data from the Piemonte and Valle d'Aosta ALS register (PARALS) was used to estimate the trends in incidence and prevalence from 2005 to 2019. Survival trends over this period were also assessed.
Rosario Vasta, Stefano Callegaro, Antonio Canosa, Umberto Manera, Maurizio Grassano, Francesca Palumbo, Sara Cabras, Enrico Matteoni, Francesca Di Pede, Filippo De Mattei, Salvatore Tafaro, Neil M. Thakur, Ryan Grosenick, Fabiola De Marchi, Letizia Mazzini, Cristina Moglia, Andrea Calvo, Kuldip D. Dave, Adriano Chiò   +18 more
wiley   +1 more source

Partial waiver of consent to overcome translational science barriers in neonatal clinical research. [PDF]

J Clin Transl Sci
Sharma M, Diamond SE, Chancellor J, Chung S, Brown AW, Hester DM, James LP, Schootman M, Mourani PM, Courtney SE.   +9 more
europepmc   +1 more source

194 Increasing COVID-19 vaccine uptake through community engagement: collaborative efforts among Cooperative Extension and Clinical and Translational Science Institutes [PDF]

Linda B. Cottler, Catherine W. Striley, LaToya J. O’Neal, Lori Bilello, Gia Mudd Martin, Kevin Everett, Milton Eder, Hal Strelnick, Joedrecka S. Brown Speights, Sergio Aguilar‐Gaxiola, Catina O’Leary   +10 more
openalex   +1 more source

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu, Oliver Robinson, Christina M. Lill, Anna Matton, Raquel Puerta, Pilar Sanz, Merce Boada, Agustín Ruiz, Lefkos Middleton, for the Alzheimer's Disease Neuroimaging Initiative   +9 more
wiley   +1 more source

Introducing JACC: Basic to Translational Science

JACC: Basic to Translational Science, 2016
Douglas L. Mann, MD, Brian H. Annex, MD, Nanette H. Bishopric, MD, Thomas Force, MD, Daniel P. Kelly, MD, Peter Libby, MD, Robert Roberts, MD, Eva van Rooij, PhD, Gordon Tomaselli, MD, L. Kristin Newby, MD, MHS   +9 more
doaj   +1 more source

Developing a stakeholder-informed social responsibility model for translational science. [PDF]

PLoS One
Smith EMR, Loutrianakis G, Beatty K, Bohn K, Cunningham KA, Croisant S, Farroni JS, Gienger M, Guinn D, Hawkins-Sneed J, Mathur S, McNamara V, Miller M, Molldrem S, Pounds K, Subrahmanyam V, Tumilty E, Loudd GA.   +17 more
europepmc   +1 more source

Translational Science Model for Designing of Outdoor Environments for Stress Relief in an Educational Institute

, 2014
Raveena Chauhan, Arnav Moulik
openalex   +1 more source

The MMP‐9/TIMP‐1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the utility of cerebrospinal fluid (CSF) biomarkers—matrix metalloproteinase‐9 (MMP‐9), tissue inhibitor of metalloproteinases‐1 (TIMP‐1), the MMP‐9/TIMP‐1 ratio, and osteopontin (OPN)—as indicators of blood–brain barrier (BBB) integrity and disease activity in people with relapsing–remitting multiple sclerosis (pwMS ...
Ivan Pavlovic, Ida Erngren, Kim Kultima, Anders Larsson, Malin Müller, Anna Wiberg, Joachim Burman   +6 more
wiley   +1 more source

Evidence-based strategies for delivering grant writing skills to clinical and translational science faculty in the Mountain West. [PDF]

J Clin Transl Sci
Dagda RK, Myaskovsky L, Sood A, Conway K, Guerrero Lopez J, Burge M, Evangelista LS, Sy FS.   +7 more
europepmc   +1 more source